Genecis Bioindustries and Helian Polymers collaborate to develop innovative PHA-based formulations

Canada-based biotechnology company Genecis Bioindustries has announced a new collaboration with Helian Polymers, a Netherlands-based supplier of biopolymer masterbatch solutions, compounds and additives
.
The two companies will collaborate to develop new material solutions based on the PHA family of materials
.

Genecis has developed a technology that converts food and other organic waste into high-value PHA materials
.
The company is a Silicon Valley Y Combinator incubation program that has received millions of dollars in government funding
.
The rapid scale-up model created by the company allows high-throughput production capacity by adding the technology to biogas plants
.
The company is currently expanding into the European Union
.

Helian Polymers has nearly 15 years of experience in biopolymers including PHA
.
In response to growing regulatory pressure and an increasingly negative attitude towards plastics, Helian Polymers has recently consolidated this expertise under a new brand called PHAradox, launching in summer 2021
.

When formulated properly, PHAs have a large design space and a corresponding range of applications
.
PHAradox specializes in fine-tuning PHA formulations, developing custom PHA blends to meet the specific needs of customers
.

Helian is the sister company of colorFabb, a leading European 3D printing company that pioneered the development of PHA and PLA/PHA blended filaments
.

Under the new partnership, the two companies will develop compounds based on PHA materials produced by Genecis for applications ranging from 3D printing filaments to biomedical solutions
.

The collaboration will maximize benefits from the strengths of both companies, paving the way for the development of new bio-based and biodegradable formulations, while offering properties close to traditional fossil-based plastics
.